Evidence map›Paper›PMID 24586162›Full record

ArticlePLoS pathogens2014

The Chlamydia trachomatis type III secretion chaperone Slc1 engages multiple early effectors, including TepP, a tyrosine-phosphorylated protein required for the recruitment of CrkI-II to nascent inclusions and innate immune signaling.

Yi-Shan Chen, Robert J Bastidas, Hector A Saka, Victoria K Carpenter, Kristian L Richards, Gregory V Plano, Raphael H Valdivia

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 76 papers.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

76 citing papers in PubMed, 107 citations in OpenAlex.

  1. Article
  2. Review
  3. ThemBio · 2026
    Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. mSphere · 2025
    Article
  11. Article
  12. Article
  13. The T3SS structural and effector genes ofFrontiers in cellular and infection microbiology · 2025
    Article
  14. mBio · 2024
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Dynamin-dependent entry ofResearch square · 2023
    Article
  20. Type III Secretion inMicrobiology and molecular biology reviews : MMBR · 2023
    Review

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Yi-Shan ChenDepartment of Molecular Genetics and Microbiology and Center for Microbial Pathogenesis, Duke University Medical Center, Durham, North Carolina, United States of America ; Department of Biochemistry, Duke University Medical Center, Durham, North Carolina, United States of America.
Robert J BastidasDepartment of Molecular Genetics and Microbiology and Center for Microbial Pathogenesis, Duke University Medical Center, Durham, North Carolina, United States of America.
Hector A SakaDepartment of Molecular Genetics and Microbiology and Center for Microbial Pathogenesis, Duke University Medical Center, Durham, North Carolina, United States of America.
Victoria K CarpenterDepartment of Molecular Genetics and Microbiology and Center for Microbial Pathogenesis, Duke University Medical Center, Durham, North Carolina, United States of America.
Kristian L RichardsDepartment of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, Florida, United States of America.
Gregory V PlanoDepartment of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, Florida, United States of America.
Raphael H ValdiviaDepartment of Molecular Genetics and Microbiology and Center for Microbial Pathogenesis, Duke University Medical Center, Durham, North Carolina, United States of America.
Duke Medical Center · USUniversity of Miami · US

Funding

ORGANIZATION AND FUNCTIONS OF CELLULAR STRUCTUREST32GM007184 · NIGMS · DUKE UNIVERSITY · PI JINKS-ROBERTSON, SUE · 1985 to 2019
$18.2M
Control of virulence protein export in Yersinia pestisR01AI039575 · NIAID · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI PLANO, GREGORY V · 2001 to 2011
$3.3M
Forward and Reverse Genetics in ChlamydiaR01AI100759 · NIAID · DUKE UNIVERSITY · PI VALDIVIA, RAPHAEL H · 2012 to 2016
$2.2M
Chlamydia Effector ProteinsR01AI081694 · NIAID · DUKE UNIVERSITY · PI VALDIVIA, RAPHAEL H · 2010 to 2014
$1.9M
CONTROL OF VIRULENCE PROTEIN EXPORT IN YERSINIA PESTISR29AI039575 · NIAID · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI PLANO, GREGORY V · 1996 to 2000
$112k
STRUCTURAL ANALYSIS OF PROMISCUOUS CHEMOKINE BINDINGF32AI010007 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI SOHL, JULIE L · 1998 to 2001
$57k
NIAID NIH HHS AI039575NIAID NIH HHS AI081694NIAID NIH HHS AI1000759NIAID NIH HHS R01 AI039575NIAID NIH HHS R01 AI081694NIAID NIH HHS R01 AI100759NIAID NIH HHS R29 AI039575NIGMS NIH HHS T32 GM007184
6 · The paper itself

Abstract

Chlamydia trachomatis, the causative agent of trachoma and sexually transmitted infections, employs a type III secretion (T3S) system to deliver effector proteins into host epithelial cells to establish a replicative vacuole. Aside from the phosphoprotein TARP, a Chlamydia effector that promotes actin re-arrangements, very few factors mediating bacterial entry and early inclusion establishment have been characterized. Like many T3S effectors, TARP requires a chaperone (Slc1) for efficient translocation into host cells. In this study, we defined proteins that associate with Slc1 in invasive C. trachomatis elementary bodies (EB) by immunoprecipitation coupled with mass spectrometry. We identified Ct875, a new Slc1 client protein and T3S effector, which we renamed TepP (Translocated early phosphoprotein). We provide evidence that T3S effectors form large molecular weight complexes with Scl1 in vitro and that Slc1 enhances their T3S-dependent secretion in a heterologous Yersinia T3S system. We demonstrate that TepP is translocated early during bacterial entry into epithelial cells and is phosphorylated at tyrosine residues by host kinases. However, TepP phosphorylation occurs later than TARP, which together with the finding that Slc1 preferentially engages TARP in EBs leads us to postulate that these effectors are translocated into the host cell at different stages during C. trachomatis invasion. TepP co-immunoprecipitated with the scaffolding proteins CrkI-II during infection and Crk was recruited to EBs at entry sites where it remained associated with nascent inclusions. Importantly, C. trachomatis mutants lacking TepP failed to recruit CrkI-II to inclusions, providing genetic confirmation of a direct role for this effector in the recruitment of a host factor. Finally, endocervical epithelial cells infected with a tepP mutant showed altered expression of a subset of genes associated with innate immune responses. We propose a model wherein TepP acts downstream of TARP to recruit scaffolding proteins at entry sites to initiate and amplify signaling cascades important for the regulation of innate immune responses to Chlamydia.

Indexed as

Amino Acid SequenceChlamydia trachomatisChromatography, LiquidFluorescent Antibody TechniqueHeLa CellsHumansImmunity, InnateImmunoprecipitationMolecular ChaperonesMolecular Sequence DataOligonucleotide Array Sequence AnalysisPhosphorylationProto-Oncogene Proteins c-crkReal-Time Polymerase Chain ReactionSignal TransductionTandem Mass SpectrometryMolecular ChaperonesProto-Oncogene Proteins c-crk

Identifiers

PMID24586162
PMCPMC3930595
OpenAlexW2067471984

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.